Cidara Therapeutics Inc buy Sievi
Start price
14.12.21
/
0%
€1.10
Target price
14.12.22
-
Performance (%)
-13.91%
End price
10.01.22
€0.95
Summary
This prediction ended on 10.01.22 with a price of €0.95. The prediction for Cidara Therapeutics Inc disappointed with a performance of -13.91%. This prediction was marked as speculative and is excluded from Sievi's performance statistics.Performance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Cidara Therapeutics Inc | - | - | - |
iShares Core DAX® | 0.476% | -0.039% | 13.342% |
iShares Nasdaq 100 | 1.290% | 0.504% | 40.099% |
iShares Nikkei 225® | 1.300% | -2.135% | 19.861% |
iShares S&P 500 | 0.829% | 0.193% | 29.756% |
According to Sievi what are the pros and cons of Cidara Therapeutics Inc for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by Sievi for this prediction
In the thread Cidara Therapeutics Inc diskutieren
Buy Cidara Therapeutics Inc